INTRODUCTION
There is considerable evidence from animal studies that activated macrophages are an important component in host resistance to tumor growth (1) (2) (3) . In vitro studies from our own and other laboratories have established that supernates from antigen-or mitogenstimulated lymphocytes contain a mediator, macrophageactivating factor (MAF),1 which enhances macrophage Dr. Churchill is the recipient of Research Career Development Award, 5 K04 CAOO116.
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The purpose of this study was to develop an in vitro system with which to compare the effect of normal and activated macrophages on both malignant and nonmalignant human target cells. We have found that human macrophages derived from peripheral blood monocytes, after being activated in vitro by mediatorrich supernates, acquire enhanced cytotoxicity for malignant targets. However, these same macrophages do not have enhanced cytotoxicity for nonmalignant targets.
METHODS
Preparation oflymphocyte supernates. Human peripheral blood mononuclear cells were isolated on a Ficoll-Hypaque (Ficoll, Pharmacia Fine Chemicals, Piscataway, N. J.; Hypaque, Winthrop Laboratories, New York) gradient after collecting the buffy coat by dextran sedimentation (10) . The cells were washed twice in Eagle's minimal essential medium that contained 100 U penicillin, 100 Ag of streptomycin, and 0.25 jig of amphotericin B/ml (MEM-PSA) and resuspended at a concentration of 2.5 x 106 cells/ml in MEM-PSA supplemented with 10% human AB+ serum and 1% L-glutamine (10% MEM-PSA) (Grand Island Biological Co., Grand Island, N. Y.).
Cells were incubated for 48 h at 37°C in a 5% CO2 95% air Eagle's minimal essential medium supplemented with 100 U of penicillin, 100 j.g of streptomycin, 0.25 iLg of amphotericin B/ml, 15% heat-inactivated fetal calf serum, and 1% L-glutamine.
2 For purposes ofthis paper we chose to define macrophages that have acquired enhanced cytotoxicity as a result of MAF treatment, as activated macrophages.
atmosphere with or without 50 U/ml streptokinase-streptodornase varidase (SK-SD) (American Cyanamid Co., Lederle Laboratories Div., Pearl River, N. Y. (12) . These four cell lines were grown in McCoy's medium supplemented with 15% heat-inactivated fetal calf serum (FCS), 1% L-glutamine, 100 U of penicillin, 100 ,ug of streptomycin, and 0.25 ,ug of amphotericin B. The fifth cell line, SK-Mes-1, was derived from a squamous cell carcinoma of the lung and was maintained in MEM-PSA medium that contained 15% heatinactivated FCS, 1% L-glutamine, and 1% nonessential amino acids.
MA-160, a long-term tissue culture line originating from a prostatic nodule was obtained from Microbiological Associates, Walkersville, Md. and was grown in MEM-PSA supplemented with 15% heat-inactivated FCS and 1% L-glutamine. This cell line now has malignant growth characteristics in that it has lost contact inhibition.
Normal cell lines. WI-38 and M-7, derived from diploid human embryonic lung cells, were grown in MEM-PSA supplemented with 1% L-glutamine and 1% heat-inactivated FCS. MA-112, derived from a whole human embryo was also grown in the above medium.
MRC-5, also obtained from human embryonic lung cells, was grown in MEM-PSA supplemented with 8% heatinactivated FCS and 1% L-glutamine. MA-349, derived from human embryonic intestinal cells, was grown in MEM-PSA supplemented with 10% heat-inactivated FCS and 1% L-glutamine.
Preparation of target cells for cytotoxic assay. All target cells were cultured as monolayers in 250-ml plastic culture flasks (Falcon Labware). The target cells were labeled by replacing the culture medium with fresh medium that contained 20 uCi [3H]thymidine ([methyl-3H]thymidine, 40-60 Ci/mmol sp act, New England Nuclear, Boston, Mass.). After 24-h incubation, the labeled monolayers were washed with MEM-PSA and trypsinized with 4 ml of 0.25% trypsin-EDTA for 10 min at 37°C. The reaction was stopped by the addition of4 ml of MEM-PSA supplemented with 15% heat-inactivated FCS and 1% L-glutamine (TCM). After washing the cells twice in TCM, the cell suspension was adjusted to a concentration of 25,000 target cells/ml. Cytotoxicity assay. After 5 d ofmaturation and an additional 2 d of incubation in mediator-rich or control supernates, the macrophage monolayers were washed twice with warm (37°C) MEM-PSA, overlaid with 200 ul of the target cell suspension, and incubated at 37°C in a moist atmosphere of 5% CO2 in air. After an incubation period of 24 h, the plates were washed twice with saline. (The optimal period of cocultivation was found to be between 6 and 24 h). The number of tumor cells remaining in the wells was then determined by the assessment of residual adhering radioactivity, as has been described previously (4) .
Determination ofmacrophage number. Because the degree of cytotoxicity of activated macrophages was calculated by comparing the residual adherent radioactivity in wells that contained an equal number of activated and control macrophages, it was necessary to count the number of cells in the monolayers at the time of addition of target cells.
The number of macrophages in monolayers prepared in parallel with the experimental monolayers was determined as follows: the macrophage monolayers were washed twice with 200 yl of Eagle's minimal essential medium, 50 ,lp of 1% xylocaine was added to each well, and the cells were incubated at 37°C for 20 min. 50 ,ul of MEM-PSA that contained 15% FCS then were added, after which the detached cells were collected and counted on the Coulter counter (Coulter Electronics Inc., Hileah, Fla.). Microscopic examination showed no residual cells in the wells after the treatment. The cell numbers from three monolayers were used to calculate the mean cell number.
Generation of in vitro sensitized lymphocytes. Mononuclear cells were suspended at a concentration of 5 x 106 cells/ml in 10% MEM-PSA. The various target cells utilized in these experiments were treated with 5 ml of mitomycin C (50 ,ug/ml) for 30 min at 37°C. The flasks were then washed three times with MEM-PSA to remove all remaining mitomycin C. 10 ml of the mononuclear cell suspension was then added to the various treated target cells. As a control, mononuclear cells were incubated in a flask without target cells. After incubation at 370C for 7 d, the nonadherent cells were removed from each flask, washed twice in MEM-PSA, and their cytotoxic effects determined. To assay for cytotoxicity, control lymphocytes or lymphocytes previously cultured with mitomycin C-treated cells were mixed with [3H]thymidine-labeled target cells at a ratio of 50:1. These mixtures were then plated in microtiter plates and incubated at 37°C. After 24 h of incubation, the residual adherent radioactivity was determined.
Calculation ofresults. Because all target cells used in this study were adherent, the loss of radioactivity from the microtiter wells was used as a measure of a cell's cytotoxicity. That this was a legitimate assay for cytotoxicity is shown in Results. To use the data derived from the several effector target cell ratios employed in each experiment, residual adherent radioactivity in microtiter wells that contained activated or control macrophages was plotted as a function of the number of macrophages present at the time of addition of tumor cells. The data was then analyzed by simple linear regression by least squares (13) , with the additional requirement that both lines pass through the same intercept on the ordinate. In this case the sum of the errors above and below the lines are not necessarily equal as they would be in simple linear regression without this additional constraint. This point represents target cells in the absence of macrophages and thus this is the same for each line. The one regression line drawn represents the number of target cells left after treatment with mediator-activated macrophages and the other represents the number of target cells remaining after treatment with control macrophages. The 
RESULTS
Cytotoxicity of mediator-activated macrophages. In these experiments normal monocyte-derived macrophages activated in vitro with lymphocyte mediator-rich supemates were consistently cytotoxic for the several target cells tested. Dose-response curves for several experiments are shown in Fig. 1 . The residual radioactivity adhering to macrophage monolayers is plotted on a logarithmic scale on the ordinate and the number of macrophages remaining at the time of addition of labeled tumor cells is plotted on the abscissa. Although there was a linear decrease in the survival oftumor cells with increasing numbers of normal macrophages, the wells that contained activated macrophages consistently had less residual radioactivity than did wells that contained macrophages treated with control supernates. After establishing the line of best fit for both activated and control macrophages, the percentage of cytotoxicity was calculated from the adherent radioactivity at a macrophage target cell ratio of 20:1. The data from ten of these experiments is shown in Table I Table II . In each experiment, the cell pellet spun from the supernates that contained mixtures of either activated or control macrophages with tumor had the same amount of radioactivity. In the mixtures of tumor with either activated or control macrophages, the loss of adherent radioactivity was associated with a corresponding increase in the radioactivity of the cell-free supernate. Thus, the relatively greater radioactivity in supernates from the mixture that contained activated macrophages is a measure of the macrophage-induced Duration of mediator-induced macrophage cytotoxicity. It is known that mediator-activated macrophages in the mouse lose their cytotoxic capacity for tumor cells in vivo or in vitro within a few hours after removal of mediator-rich supernates (6, 14) . Therefore, we attempted to establish whether continued exposure to MAF was required to maintain the cytotoxic capacity of human macrophages. In several experiments, the macrophages were activated for 8 h with mediator-rich supernates, washed, and cultured for another 40 h in fresh tissue culture medium to determine if human macrophages retain the ability to kill tumor cells once the activation factor has been removed.
As shown in Table III , mediator-activated human macrophages can still kill tumor cells effectively even if the MAF is removed 40 h before assay. The extent of kill after 8 h of activation is in the same range as when the macrophages are exposed to MAF for 8 h and then maintained in TCM for an additional 40 h before testing.
Because maximal cytotoxicity occurs after 24-h activation (Fig. 2) Lack of macrophage-mediated cytotoxicity for normal human target cells. To determine whether macrophage-mediated cytotoxicity was nonspecifically directed against any type of target cell, or restricted to Macrophages incubated with mediator-rich supernates were not cytotoxic for the five normal cell lines tested (Table V) . In contrast, these macrophages were cytotoxic for the SK-BR-3 or MA-160 tumor cells that were tested in parallel.
Because these targets were not sensitive to the effects of cytotoxic macrophages, it was important to demonstrate that these same targets could be killed by another immunological mechanism. Human mononuclear cells were incubated with mitomycin C-treated WI-38, MRC-5, or M-7 cells. As a control, another aliquot of mononuclear cells was incubated in a flask without added target cells. After 7-d incubation, the nonadherent cells from stimulated and control cultures were washed and then cocultivated with each oftheir respective radiolabeled target cells. The results are shown in Table VI . All target cells tested were killed by the in vitro sensitized lymphocytes although mediatoractivated macrophages had little or no effect on the same targets.
Relationship between target cell replication rate and susceptibility to the effects of mediator-activated macrophages. It has been previously suggested that sensitivity to macrophage-mediated cytotoxicity is related to rate of cell division (15) . Table VII summarizes the doubling times for these cell lines and shows no correlation between doubling time and sensitivity to macrophage-mediated cytotoxicity. In the first experiment, SK-BR-3, one of the two most sensitive targets, had one of the shortest doubling times, Killing of Human Tumor Cells by Human Macrophages (17) (18) (19) and to bacterial infections (20) . However, before the present study it was not known whether treatment of human macrophages with MAF-rich supernates from antigenstimulated lymphocytes would enhance their cytotoxicity for human target cells.
Enhancement of monocyte-derived macrophage cytotoxicity by MAF is observed after 8 h of incubation, is maximum after 24 -h activation, and lasts for at least 40 h after removal of MAF from the macrophages. The kinetics of induction of macrophage-mediated cytotoxicity for guinea pig and mouse macrophages is similar in that it is first observed after 8-h activation (6) .3 However, animal macrophages are unlike human macrophages in that the cytotoxic capacity is not detectable within a few hours after removal of mediatorrich supernates (6, 14) .
The time required for activated macrophages to kill target cells is similar to that previously found for guinea pig macrophages (4, 5, 21) and is shorter than that needed for mouse macrophages (22, 23) . By presumably important in the process of macrophagemediated cytotoxicity (21, 24) . Activated guinea pig macrophages have enhanced binding to malignant as compared to normal target cells (25) . It is possible that the increased binding to malignant targets is in some way related to the greater susceptibility of these targets to the effects of mediator-activated macrophages. Alternatively, the increased susceptibility of malignant targets may relate to a more rapid cell division. However, we did not find any correlation between target cell sensitivity to macrophages and the rate of replication. Because monocytes are precursors of macrophages, it is possible that the capacity to respond to MAF may be one of the functions developed during the period of in vitro culture. When peripheral blood monocytes were tested immediately after explantation and activation, enhanced cytotoxicity was not observed. How long monocytes must be incubated in vitro before they acquire the capacity to respond to MAF remains to be established.
Several other groups have reported related findings. Gougerot et al. (26) have shown that human peritoneal macrophages, incubated with cell-free supernates prepared from human mixed-lymphocyte cultures, render macrophages cytotoxic for Cr5l-labeled KB tumor cells. Human peripheral blood monocytes were also found to be cytotoxic for the KB cells; however, this cytotoxicity was neither consistent nor as strong as that with the peritoneal macrophages.
Normal unstimulated macrophages have been shown to be cytotoxic to HeLa cells (9) . In addition, Hersch et al. (27) have found that macrophages activated by concanavalin A-induced mediators cause growth inhibition but not cytotoxicity of the HeLa cells (27) .
Rinehart et al. (8) , with a postlabeling technique, have studied the effect of unstimulated blood monocytes on several tissue culture lines, among which is one we have studied (Sk-Mes-1). They found that addition of monocytes to targets caused cytostasis and(or) cytotoxicity. The effect correlated with the monocyte target cell ratio, was maximum at 24 h and was observed with four different targets. Our studies examined the effect of monocyte-derived macrophages on prelabeled target cells and thus are not analogous to their findings. These methodologic differences may explain the different results obtained in our studies. We observed (Table I ) some cytotoxicity by control macrophages but not to the same extent as found by Rinehart et al. (8) .
The role of macrophages in host resistance to tumor growth in man is still largely undefined. Animal studies that suggest a role for macrophages include histologic observation of regressing tumors, studies of delayed hypersensitivity to tumor extracts, and a variety of in vitro studies showing evidence of cell-mediated immunity to tumor targets (1-3). Much less is known about the interaction of human macrophages with tumor. Macrophages from patients with cancer are known to have impaired chemotaxis (28) , possibly a result of an inhibitor produced by the tumor (29) . Aside from these observations, relatively little is known about whether macrophages from patients with cancer have different responses to tumor targets than normal macrophages.
In patients with cancer, defective macrophage cytotoxicity may be caused by abnormalities in base-line cytotoxicity or in the enhancement of cytotoxicity induced by lymphocyte mediators. With this assay it should now be possible to distinguish between these alternatives.
